ArticleFrontiers in neurology2024
Editorial: Epilepsy and Alzheimer's disease: shared pathology, clinical presentations, and targets for treatment.
Beth Leeman-Markowski, Jeannie Chin, Dominique Leitner, Keith Vossel
Abstract readEditorial
In one paragraphArticle in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Beth Leeman-MarkowskiNeurology Service, VA New York Harbor Healthcare System, New York, NY, United States.
Jeannie ChinDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, United States.
Dominique LeitnerDepartment of Neurology, Center for Cognitive Neurology, New York University Langone Health, New York, NY, United States.
Keith VosselDepartment of Neurology, Mary S. Easton Center for Alzheimer's Research and Care, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
Funding
Transgenic/Behavior CoreP01AG060882 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WISNIEWSKI, THOMAS M · 2020 to 2024
$12.0MIN VIVO STUDIES OF THE EPILEPTIC HIPPOCAMPUSR01NS033310 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JEROME NONE ENGEL, Richard Staba · 1994 to 2026
$7.5MAstrocyte and neuron brain-region and compartment-specific proteome dynamics in aging and Alzheimer’s diseaseR01AG075955 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KHAKH, BALJIT, VOSSEL, KEITH ALAN · 2021 to 2025
$5.2MIn Vivo Studies of the Epileptic HippocampusRF1NS033310 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ENGEL, JEROME NONE, STABA, RICHARD · 2023 to 2023
$3.6MPreventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins.R01AG058820 · NIA · UNIVERSITY OF MINNESOTA · PI VOSSEL, KEITH ALAN · 2019 to 2023
$1.9MLeveraging the Electronic Health Record and Integrating Social and Biological Data to Expand Dementia Research in Understudied Populations in Los Angeles CountyUH2AG083254 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VOSSEL, KEITH ALAN · 2023 to 2024
$1.1MHippocampal oscillations, interictal discharges, and memory formationIK2CX001255 · VA · VA MEDICAL CENTER · PI LEEMAN-MARKOWSKI, BETH AMI · 2017 to 2022
–CSRD VA IK2 CX001255NIA NIH HHS P01 AG060882NIA NIH HHS R01 AG058820NIA NIH HHS R01 AG075955NIA NIH HHS UH2 AG083254NINDS NIH HHS R01 NS033310NINDS NIH HHS RF1 NS033310
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Alzheimer's diseaseamyloidcognitiondementiaepilepsymemoryseizurestau
Identifiers
PMID39193148
PMCPMC11348586
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390